https://scholars.lib.ntu.edu.tw/handle/123456789/636487
標題: | Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysis | 作者: | Peng, Shang-Hsuan CHING-HUNG LIN I-CHUN CHEN YING-CHUN SHEN DWANG-YING CHANG WEI-WU CHEN Huang, Shu-Min Hu, Fu-Chang YEN-SHEN LU |
關鍵字: | Asian; advanced cancers; meta-analysis; overall survival; pembrolizumab | 公開日期: | 十月-2023 | 卷: | 12 | 期: | 19 | 來源出版物: | Cancer medicine | 摘要: | Immune checkpoint inhibitors have revolutionized the treatment of malignancies. However, disproportionate enrollment among races and ethnicities places the generalizability of global trial results in doubt. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/636487 | ISSN: | 2045-7634 | DOI: | 10.1002/cam4.6563 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。